Hamada K - Search Results

1

Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation.

Aoki Y, Tome Y, Han Q, Yamamoto J, Hamada K, Masaki N, Bouvet M, Nishida K, Hoffman RM. Aoki Y, et al. Among authors: hamada k. Biochem Biophys Rep. 2021 Nov 26;28:101177. doi: 10.1016/j.bbrep.2021.101177. eCollection 2021 Dec. Biochem Biophys Rep. 2021. PMID: 34877414 Free PMC article.

2

Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.

Lim HI, Hamada K, Yamamoto J, Han Q, Tan Y, Choi HJ, Nam SJ, Bouvet M, Hoffman RM. Lim HI, et al. Among authors: hamada k. In Vivo. 2020 Sep-Oct;34(5):2281-2286. doi: 10.21873/invivo.12039. In Vivo. 2020. PMID: 32871751 Free PMC article.

3

Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model.

Sugisawa N, Hamada K, Han Q, Yamamoto J, Sun YU, Nishino H, Kawaguchi K, Bouvet M, Unno M, Hoffman RM. Sugisawa N, et al. Among authors: hamada k. Anticancer Res. 2020 Sep;40(9):4869-4874. doi: 10.21873/anticanres.14489. Anticancer Res. 2020. PMID: 32878774

4

Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.

Yamamoto J, Han Q, Inubushi S, Sugisawa N, Hamada K, Nishino H, Miyake K, Kumamoto T, Matsuyama R, Bouvet M, Endo I, Hoffman RM. Yamamoto J, et al. Among authors: hamada k. Biochem Biophys Res Commun. 2020 Dec 17;533(4):1034-1038. doi: 10.1016/j.bbrc.2020.09.108. Epub 2020 Oct 3. Biochem Biophys Res Commun. 2020. PMID: 33019978

5

Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis.

Sun YU, Nishino H, Sugisawa N, Yamamoto J, Hamada K, Zhu G, Lim HI, Hoffman RM. Sun YU, et al. Among authors: hamada k. Anticancer Res. 2020 Nov;40(11):6083-6091. doi: 10.21873/anticanres.14629. Anticancer Res. 2020. PMID: 33109546

6

Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.

Nishino H, Hollandsworth HM, Sugisawa N, Yamamoto J, Tashiro Y, Inubushi S, Hamada K, Sun YU, Lim H, Amirfakhri S, Filemoni F, Hoffman RM, Bouvet M. Nishino H, et al. Among authors: hamada k. In Vivo. 2020 Nov-Dec;34(6):3153-3157. doi: 10.21873/invivo.12149. In Vivo. 2020. PMID: 33144418 Free PMC article.

7

A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer.

Sun YU, Nishino H, Zhao M, Miyake K, Sugisawa N, Yamamoto J, Tashiro Y, Inubushi S, Hamada K, Zhu G, Lim H, Hoffman RM. Sun YU, et al. Among authors: hamada k. In Vivo. 2020 Nov-Dec;34(6):3225-3231. doi: 10.21873/invivo.12158. In Vivo. 2020. PMID: 33144427 Free PMC article.

8

A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts.

Yamamoto J, Sugisawa N, Hamada K, Nishino H, Miyake K, Matsuyama R, Inubushi S, Tanino H, Bouvet M, Endo I, Hoffman RM. Yamamoto J, et al. Among authors: hamada k. Anticancer Res. 2020 Dec;40(12):6765-6768. doi: 10.21873/anticanres.14699. Anticancer Res. 2020. PMID: 33288569

9

Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model.

Sugisawa N, Yamamoto J, Han Q, Tan Y, Tashiro Y, Nishino H, Inubushi S, Hamada K, Kawaguchi K, Unno M, Bouvet M, Hoffman RM. Sugisawa N, et al. Among authors: hamada k. Pancreas. 2021 Jan 1;50(1):93-98. doi: 10.1097/MPA.0000000000001709. Pancreas. 2021. PMID: 33370029

10

Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells.

Yamamoto J, Aoki Y, Han Q, Sugisawa N, Sun YU, Hamada K, Nishino H, Inubushi S, Miyake K, Matsuyama R, Bouvet M, Endo I, Hoffman RM. Yamamoto J, et al. Among authors: hamada k. Anticancer Res. 2021 Feb;41(2):641-643. doi: 10.21873/anticanres.14815. Anticancer Res. 2021. PMID: 33517268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,676 results

Search Page